Lite Strategy, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Lite Strategy, Inc. (LITS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $5.40 million for the 12-month period ending 2020-06-30, per its 10-K filed 2020-09-09.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2020-09-09
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2020 was $5.40M, a 58.82% increase from fiscal 2019.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2019 was $3.40M, a 41.67% increase from fiscal 2018.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2018 was $2.40M, a 0.00% change from fiscal 2017.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2017 was $2.40M, a 22.58% decline from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|
| 2020-06-30 | $5.40M 10-K · filed 2020-09-09 |
| 2019-06-30 | $3.40M 10-K · filed 2020-09-09 |
| 2018-06-30 | $2.40M 10-K · filed 2020-09-09 |
| 2017-06-30 | $2.40M 10-K · filed 2019-08-28 |
| 2016-06-30 | $3.10M 10-K · filed 2018-08-30 |
| 2015-06-30 | $2.60M 10-K · filed 2017-09-05 |
| 2014-06-30 | $1.20M 10-K · filed 2016-09-06 |
| 2013-06-30 | $900.00K 10-K · filed 2015-09-02 |
| 2012-06-30 | $300.00K 10-K · filed 2014-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |